Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Norwegian University Of Science And Technolology
Sponsor

Norwegian University Of Science And Technolology

Norway Hoegskoleringen 1, 7034 Trondheim, Norway

About the sponsor

Clinical research includes treatment-focused studies in recurrent grade 3 and grade 4 glioma, with attention to therapeutic activity and tolerability in aggressive central nervous system tumours. The sponsor also supports work using PSMA theranostics in this setting.

  • Recurrent high-grade glioma
  • 177Lu-PSMA and 68Ga/177Lu-PSMA approaches
  • Safety and efficacy in brain tumour treatment

These activities reflect interest in advanced radioligand-based strategies for difficult-to-treat malignant brain disease.

About Specializations

Norwegian University Of Science And Technolology runs clinical trials in conditions such as Cluster headache, Small cell lung cancer limited stage, Dementia Alzheimer's type, Latent autoimmune diabetes in adults, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Cluster headache

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Norwegian University Of Science And Technolology

Small cell lung cancer limited stage

Not yet recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Dementia Alzheimer's type

Not recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Human Plasma Protein
  • Sponsor:Norwegian University Of Science And Technolology

Latent autoimmune diabetes in adults

Not recruiting
InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Glutamate Decarboxylase 2, Human, Recombinant
  • Sponsor:Norwegian University Of Science And Technolology

Small cell lung cancer extensive stage

Not recruiting
Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Small cell lung cancer

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Norwegian University Of Science And Technolology

Glioma

Not recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177Lu) Zadavotide Guraxetan
  • Sponsor:Norwegian University Of Science And Technolology

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.